Editorial
Published on 21 Feb 2025
Editorial: Ecosystems-centered health and care innovation
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1567993
- 225 views
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
410 articles
Articles
Review
Published on 20 Feb 2025
Defining the value proposition in diagnostic technology: challenges and opportunities for its understanding and development – a review with a multiperspective reflective analysis
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1498618
- 297 views
Original Research
Published on 19 Feb 2025
Network analysis of adverse event patterns following immunization with mRNA COVID-19 vaccines: real-world data from the European pharmacovigilance database EudraVigilance
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1501921
- 439 views
Perspective
Accepted on 17 Feb 2025
Healthcare AI, explainability, and the human-machine relationship: a (not so) novel practical challenge
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1545409
Perspective
Accepted on 17 Feb 2025
Valuing patients' high unmet need to drive innovative solutions for inherited retinal degenerations: Insights from the RIWC 2024 workshop on Value
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1481670
Original Research
Accepted on 14 Feb 2025
"The Therapeutic Futility Paradox: Insights from Oncological Drug Litigation in Ecuador"
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1434524
- 130 views
Original Research
Published on 11 Feb 2025
Acceptance of artificial intelligence clinical assistant decision support system to prevent and control venous thromboembolism among healthcare workers: an extend Unified Theory of Acceptance and Use of Technology Model
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1475577
- 223 views
Original Research
Published on 11 Feb 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1539787
- 262 views
Review
Accepted on 10 Feb 2025
Regulatory Pathways and Guidelines for Nanotechnology-Enabled Health Products: A Comparative Review of EU and US Frameworks
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1544393
Policy and Practice Reviews
Published on 10 Feb 2025
From guideline to practice: three years of ICH S11 insights and recommendations
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1537001
- 429 views
Original Research
Accepted on 04 Feb 2025
MEDICINES NOT RECOMMENDED FOR INCLUSION IN THE WHO ESSENTIAL MEDICINES LIST: A RETROSPECTIVE OBSERVATIONAL STUDY
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1517020
Systematic Review
Published on 31 Jan 2025
Re-analysis of the current status of clinical trial registration in China
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1394803
- 502 views
Original Research
Published on 30 Jan 2025
Effects of the Paediatric Regulation funding on the development of off-patent medicines in children
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1473862
- 368 views
Original Research
Published on 30 Jan 2025
Exploration of policy feedback mechanism for healthcare improvement in China: a grounded theory model
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1496836
- 384 views
Policy Brief
Published on 27 Jan 2025
Challenges and ongoing initiatives towards better integrated EU scientific advice
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1473346
- 412 views
Hypothesis and Theory
Published on 24 Jan 2025
A conceptual model and practical guidance for the development, administration, and evaluation of individualized therapies
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2025.1493832
- 542 views